Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein-Reference-Cited by-同舟云学术

Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein

Published:2006-04 Issue:1-2 Volume:536 Page:102-108
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Gillard Michel,Chatelain Pierre,Fuks Bruno

Publisher

Elsevier BV

Subject

Pharmacology

Reference20 articles.

1. SV2, a brain synaptic vesicle protein homologous to bacterial transporters;Bajjalieh;Science,1992

2. The antiepileptic drug levetiracetam decreases the IP3-dependent [Ca2+]i increase induced by ATP and BK in PC12 cells;Cataldi;J. Pharmacol. Exp. Ther.,2005

3. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1973

4. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A);Crowder;Proc. Natl. Acad. Sci. U. S. A.,1999

5. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes;De Lean;Mol. Pharmacol.,1982

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression;Neuropsychopharmacology;2024-07-22

2. Association of synaptic density and cognitive performance in temporal lobe epilepsy: Humans and animals PET imaging study with [¹⁸F]SynVesT‐1;Psychiatry and Clinical Neurosciences;2024-05-28

3. Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A;Nature Communications;2024-04-18

4. Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database;Seizure: European Journal of Epilepsy;2024-04

5. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil;Neuroscience Bulletin;2023-10-28